Submitted by Anonymous (not verified) on 23 July 2024 - 13:40
Orphan designation: 4-(4-Methyl-piperazin-1-yl)-N-{6-[2-(4-trifluoromethyl-benzyloxy)-ethoxy]-1H-indazol-3-yl}-benzamide hemioxalate Treatment of acute myeloid leukaemia, 21/03/2024 Positive
Source: